Perbandingan Homosistein Serum pada Pasien DMT2 dengan Terapi Metformin dan Kombinasi Metformin-Glimepirid = Comparison of Serum Homocysteine in T2DM Patients with Metformin and Metformin-Glimepiride Combination Therapy

Perbandingan Profil Metabolit Urin Pasien DMT2 yang Mengonsumsi Metformin-Glimepirid dengan Penyakit Ginjal Diabetes Kategori Prognosis Rendah dan Sedang = Comparison Of Urinary Metabolite Profile in T2DM Patients Consuming Metformin-Glimepiride with Diabetic Kidney Disease in the Low and Moderate Prognosis Categories

Perbandingan Metabolit Urin Pasien DMT2 yang Mengonsumsi Metformin-Glimepirid dengan Penyakit Ginjal Diabetes Risiko Sedang dan Tinggi Berdasarkan KDIGO 2022 = Comparison of Urine Metabolites of T2DM Patients Comsuming Metformin-Glimepiride with Moderate and High Risk of Diabetic Kidney Disease Based on KDIGO 2022

Perbandingan Glikosaminoglikan Urin Kelompok Risiko Rendah terhadap Risiko Sedang-Tinggi berdasarkan KDIGO 2012 pada Pasien DM Tipe 2 yang Mengonsumsi Metformin = Comparison of Urine Glycosaminoglycans in Low Risk to Medium-High Risk Groups based on 2012 KDIGO in Type 2 DM Patients Taking Metformin

Analisis Efektivitas-Biaya Terapi Kombinasi Metformin-Pioglitazon Dibandingkan Metformin-Glimepirid Pada Pasien Diabetes Melitus Tipe 2 di RSUD Pasar Rebo = Cost-Effectiveness Analysis of Therapy Combination Metformin-Pioglitazone Compared Metformin-Glimepiride on Diabetes Mellitus Type 2 Outpatients in RSUD Pasar Rebo